文献速递颅颌面外科瘢痕与激光

颅面部先天性黑色素细胞痣刮除术后的附加治疗:日本单中心报告

Additional treatments after curettage of congenital melanocytic nevi in the craniofacial region: A report from a single center in Japan.
PubMed 文献 · J Plast Reconstr Aesthet Surg · 2024-08-17

本研究回顾性分析京都大学医院2019年5月至2022年4月间以刮除术为初始治疗的23例颅面部先天性黑色素细胞痣病例,刮除术平均在3.8(1-10)月龄进行。头部病灶80%未接受附加治疗,而额部和面颊所有病例均接受附加治疗;眼睑病灶86%、鼻部病灶75%接受激光治疗,额部及面颊各33%采用组织扩张与皮瓣闭合。结论认为附加治疗方式随病灶部位而异。

要点

  • 颅面部先天性黑色素细胞痣刮除术后附加治疗方式因病灶部位不同而异。
  • 头部病灶80%无需附加治疗,额部和面颊所有病例均需附加治疗。
  • 眼睑和鼻部病灶以激光治疗为主,额部和面颊部部分病例采用组织扩张与皮瓣闭合。

核心结论

  • 颅面部先天性黑色素细胞痣刮除术后的附加治疗方式随病灶部位不同而变化。

研究设计与样本

  • 回顾性研究,纳入2019年5月至2022年4月在京都大学医院以刮除术为初始治疗的先天性黑色素细胞痣病例,共23例。

主要发现

  • 刮除术平均在3.8(1-10)月龄进行。
  • 头部先天性黑色素细胞痣80%未接受附加治疗。
  • 额部和面颊所有病例均接受附加治疗。
  • 眼睑病灶86%、鼻部病灶75%接受激光治疗。
  • 额部病灶33%、面颊病灶33%采用组织扩张与皮瓣闭合。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Congenital melanocytic nevus (CMN) is a benign skin lesion present from birth, which may present with a risk of malignant transformation if extensive. Curettage, a treatment method involving the removal of the superficial layer of the nevus, is often used in the early stages of life. However, recurrence of the nevus and postoperative scarring may present as problems. Additional treatments, such as resection and/or laser treatment, are regularly required after curettage, particularly in the craniofacial region. However, no systematic treatment strategy has been reported. This study investigated additional treatments used after curettage to treat CMN in the craniofacial region and compared the frequency of treatments with respect to specific sites. METHODS: CMN cases involving curettage as an initial treatment were retrospectively reviewed at Kyoto University Hospital between May 2019 and April 2022. RESULTS: This study comprised 23 cases. Curettage was performed at a mean of 3.8 (1-10) months of age. No additional treatments were provided for 80% of head CMN. Additional treatments were performed in all cases, including the forehead and cheek. Laser treatment was performed in 86% of eyelid CMN and 75% of nasal CMN. Tissue expansion and flap closure were used in 33% of forehead CMN and 33% of cheek CMN. CONCLUSIONS: Additional treatments used for CMN in the craniofacial region varied in accordance with the lesion site.

来源:J Plast Reconstr Aesthet Surg,查看原文。版权归原作者所有。

引用

  1. Masuno H, Sakamoto M, Katayama Y, et al. Additional treatments after curettage of congenital melanocytic nevi in the craniofacial region: A report from a single center in Japan. J Plast Reconstr Aesthet Surg. 2024. PMID: 39243714. doi:10.1016/j.bjps.2024.08.058

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。